Lai Y, Hickey RW, Chen Y, Bayir H, Sullivan ML, Chu CT et al
This study joins the ranks of previous publications demonstrating the potential neuroprotective effect of GLP-1 receptor agonists in glaucoma and suggests a need for further prospective trials
Consequently, the clinical applications of these interventions warrant further investigation
While side effects are minimal, some patients may experience temporary swelling, bruising, or redness at the injection site
Kidney Damage is also a risk associated with GLP and Ozempic use
Anything that is going to produce robust weight loss, theres going to be a percentage of that thats muscle, Caroline Apovian, an obesity medicine specialist at Harvard Medical School and at Brigham and Womens Hospital in Boston, told Scientific American